financetom
Business
financetom
/
Business
/
BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem
Oct 29, 2025 3:20 AM

Oct 29 (Reuters) - NLS Pharmaceutics AG ( NLSP ):

* NLS PHARMACEUTICS LTD. ANNOUNCES 1-FOR-10 REVERSE SHARE

SPLIT

AND NAME CHANGE IN CONNECTION WITH PROPOSED MERGER WITH

KADIMASTEM

* NLS PHARMACEUTICS ( NLSP ) - REVERSE SPLIT EFFECTIVE IN SWITZERLAND

ON

OCTOBER 30, 2025

* NLS PHARMACEUTICS ( NLSP ) - COMMON SHARES TO TRADE ON NASDAQ AS

NCEL

UNDER NEW NAME NEWCELX LTD

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved